论文部分内容阅读
我们曾用天津医药工业研究所试制的安他唑啉治疗86例心律失常患者,其中男49例,女37例,年龄为15～66岁。诊断为冠心病24例,心肌炎后遗症17例,高血压病11例,乙链感染后综合征5例,病毒性心肌炎2例,冠心病合并甲亢性心脏病1例,风心病1例和原因不明25例。经心电图证实为室性早搏45例,房性早搏12例,房性早搏伴室性早搏2例,交界性早搏2例,交界性早搏伴室性早搏1例,窦性心动过速20例,阵发性室上性心动过速2例,室性早搏伴短阵室性心动过速及快速房颤1例和房性早搏伴房性心动过速1例。病程为1月～5年。均为住院病例。
We have used the Tianjin Institute of Pharmaceutical Industry trial of 86 cases of arotanacrine treatment of arrhythmia patients, 49 males and 37 females, aged 15 to 66 years. Diagnosis of coronary heart disease in 24 cases, 17 cases of myocarditis sequelae, hypertension in 11 cases, 5 cases of post-B-chain syndrome, viral myocarditis in 2 cases, coronary heart disease with hyperthyroidism heart disease in 1 case, rheumatic heart disease in 1 case and unknown cause 25 cases. ECG confirmed by ventricular premature beats in 45 cases, atrial premature beats in 12 cases, atrial premature beats with ventricular premature beats in 2 cases, borderline premature beats in 2 cases, borderline premature beats with ventricular premature beats in 1 case, sinus tachycardia in 20 cases, 2 cases of paroxysmal supraventricular tachycardia, ventricular premature beats with paroxysmal ventricular tachycardia and rapid atrial fibrillation in 1 case and atrial premature beats with atrial tachycardia in 1 case. Duration of 1 month to 5 years. Are hospitalized cases.